vs

Side-by-side financial comparison of Inogen Inc (INGN) and XPEL, Inc. (XPEL). Click either name above to swap in a different company.

XPEL, Inc. is the larger business by last-quarter revenue ($122.3M vs $68.6M, roughly 1.8× Inogen Inc). On growth, XPEL, Inc. posted the faster year-over-year revenue change (13.7% vs 3.4%). XPEL, Inc. produced more free cash flow last quarter ($1.6M vs $-1.9M). Over the past eight quarters, XPEL, Inc.'s revenue compounded faster (16.5% CAGR vs 4.2%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

XPEL, Inc. is a global provider of high-performance surface protection solutions primarily for automotive use. Core offerings include paint protection films, window tints, and ceramic coatings, serving vehicle owners, dealerships, and professional installers across North America, Europe, and Asia Pacific.

INGN vs XPEL — Head-to-Head

Bigger by revenue
XPEL
XPEL
1.8× larger
XPEL
$122.3M
$68.6M
INGN
Growing faster (revenue YoY)
XPEL
XPEL
+10.3% gap
XPEL
13.7%
3.4%
INGN
More free cash flow
XPEL
XPEL
$3.5M more FCF
XPEL
$1.6M
$-1.9M
INGN
Faster 2-yr revenue CAGR
XPEL
XPEL
Annualised
XPEL
16.5%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
XPEL
XPEL
Revenue
$68.6M
$122.3M
Net Profit
$13.4M
Gross Margin
51.4%
41.9%
Operating Margin
-13.6%
12.7%
Net Margin
11.0%
Revenue YoY
3.4%
13.7%
Net Profit YoY
50.7%
EPS (diluted)
$-0.26
$0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
XPEL
XPEL
Q4 25
$68.6M
$122.3M
Q3 25
$79.1M
$125.4M
Q2 25
$79.2M
$124.7M
Q1 25
$68.5M
$103.8M
Q4 24
$66.3M
$107.5M
Q3 24
$74.9M
$112.9M
Q2 24
$74.4M
$109.9M
Q1 24
$63.1M
$90.1M
Net Profit
INGN
INGN
XPEL
XPEL
Q4 25
$13.4M
Q3 25
$-5.3M
$12.9M
Q2 25
$-4.2M
$16.3M
Q1 25
$-6.2M
$8.6M
Q4 24
$8.9M
Q3 24
$-6.0M
$14.9M
Q2 24
$-5.6M
$15.0M
Q1 24
$-14.6M
$6.7M
Gross Margin
INGN
INGN
XPEL
XPEL
Q4 25
51.4%
41.9%
Q3 25
52.2%
41.8%
Q2 25
52.2%
42.9%
Q1 25
53.1%
42.3%
Q4 24
54.7%
40.6%
Q3 24
55.2%
42.5%
Q2 24
57.4%
43.5%
Q1 24
54.5%
42.0%
Operating Margin
INGN
INGN
XPEL
XPEL
Q4 25
-13.6%
12.7%
Q3 25
-9.0%
13.4%
Q2 25
-7.7%
15.5%
Q1 25
-11.2%
10.7%
Q4 24
-17.2%
11.5%
Q3 24
-10.4%
16.3%
Q2 24
-9.5%
17.5%
Q1 24
-25.8%
10.2%
Net Margin
INGN
INGN
XPEL
XPEL
Q4 25
11.0%
Q3 25
-6.7%
10.3%
Q2 25
-5.2%
13.1%
Q1 25
-9.0%
8.3%
Q4 24
8.3%
Q3 24
-8.0%
13.2%
Q2 24
-7.5%
13.7%
Q1 24
-23.1%
7.4%
EPS (diluted)
INGN
INGN
XPEL
XPEL
Q4 25
$-0.26
$0.48
Q3 25
$-0.20
$0.47
Q2 25
$-0.15
$0.59
Q1 25
$-0.25
$0.31
Q4 24
$-0.41
$0.33
Q3 24
$-0.25
$0.54
Q2 24
$-0.24
$0.54
Q1 24
$-0.62
$0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
XPEL
XPEL
Cash + ST InvestmentsLiquidity on hand
$103.7M
$50.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$192.2M
$280.3M
Total Assets
$298.6M
$382.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
XPEL
XPEL
Q4 25
$103.7M
$50.9M
Q3 25
$106.5M
$64.5M
Q2 25
$103.7M
$49.6M
Q1 25
$118.9M
$23.5M
Q4 24
$113.8M
$22.1M
Q3 24
$105.7M
$21.0M
Q2 24
$97.9M
$15.0M
Q1 24
$107.4M
$8.6M
Stockholders' Equity
INGN
INGN
XPEL
XPEL
Q4 25
$192.2M
$280.3M
Q3 25
$197.2M
$269.3M
Q2 25
$199.5M
$255.7M
Q1 25
$198.0M
$235.5M
Q4 24
$173.9M
$225.5M
Q3 24
$185.4M
$218.7M
Q2 24
$187.6M
$201.9M
Q1 24
$191.9M
$186.4M
Total Assets
INGN
INGN
XPEL
XPEL
Q4 25
$298.6M
$382.5M
Q3 25
$307.0M
$387.7M
Q2 25
$312.0M
$318.1M
Q1 25
$308.4M
$294.8M
Q4 24
$296.2M
$285.6M
Q3 24
$306.2M
$273.0M
Q2 24
$308.9M
$261.8M
Q1 24
$315.6M
$258.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
XPEL
XPEL
Operating Cash FlowLast quarter
$-943.0K
$2.7M
Free Cash FlowOCF − Capex
$-1.9M
$1.6M
FCF MarginFCF / Revenue
-2.8%
1.3%
Capex IntensityCapex / Revenue
1.4%
0.9%
Cash ConversionOCF / Net Profit
0.20×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M
$62.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
XPEL
XPEL
Q4 25
$-943.0K
$2.7M
Q3 25
$2.2M
$33.2M
Q2 25
$4.3M
$27.9M
Q1 25
$-16.8M
$3.2M
Q4 24
$-3.0M
$6.3M
Q3 24
$7.0M
$19.6M
Q2 24
$6.7M
$26.9M
Q1 24
$-4.7M
$-5.0M
Free Cash Flow
INGN
INGN
XPEL
XPEL
Q4 25
$-1.9M
$1.6M
Q3 25
$1.6M
$32.2M
Q2 25
$3.7M
$26.9M
Q1 25
$-17.1M
$2.2M
Q4 24
$-3.3M
$4.7M
Q3 24
$5.3M
$18.3M
Q2 24
$6.6M
$25.1M
Q1 24
$-6.1M
$-7.0M
FCF Margin
INGN
INGN
XPEL
XPEL
Q4 25
-2.8%
1.3%
Q3 25
2.0%
25.6%
Q2 25
4.6%
21.6%
Q1 25
-24.9%
2.1%
Q4 24
-5.0%
4.4%
Q3 24
7.1%
16.2%
Q2 24
8.9%
22.8%
Q1 24
-9.6%
-7.7%
Capex Intensity
INGN
INGN
XPEL
XPEL
Q4 25
1.4%
0.9%
Q3 25
0.7%
0.8%
Q2 25
0.9%
0.8%
Q1 25
0.4%
1.0%
Q4 24
0.5%
1.5%
Q3 24
2.2%
1.1%
Q2 24
0.1%
1.6%
Q1 24
2.1%
2.2%
Cash Conversion
INGN
INGN
XPEL
XPEL
Q4 25
0.20×
Q3 25
2.56×
Q2 25
1.71×
Q1 25
0.38×
Q4 24
0.71×
Q3 24
1.31×
Q2 24
1.79×
Q1 24
-0.74×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

XPEL
XPEL

Products$90.9M74%
Service Revenue Installation Labor$23.8M19%
Service Revenue Cutbank Credits$4.1M3%
Service Revenue Software$2.2M2%

Related Comparisons